P07355 (ANXA2_HUMAN) Homo sapiens (Human)

Annexin A2 UniProtKBInterProSTRINGInteractive Modelling

339 aa; Sequence (Fasta) ; (Isoform 2); 21 identical sequences

Available Structures

41 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of Annexin A2 complexed with S100A4 Heteromer
P26447;
2-339
99.714×CA;GOL;
The third PDZ domain of PDZD7 complexed with the PDZ-binding motif of EXOC4 Heteromer
Q96A65; Q9H5P4;
22-339
99.68CA;GOL;
The PDZ domain of SYNJ2BP complexed with the phosphorylated PDZ-binding motif of RSK1 Heteromer
P57105; Q15418;
22-339
99.69CA;GOL;
The PDZ-domain of SNTB1 complexed with the PDZ-binding motif of HPV35-E6 Heteromer
P27228; Q13884;
22-339
99.69CA;GOL;
The PDZ domain of SNTG1 complexed with the acetylated PDZ-binding motif of PTEN Heteromer
P60484; Q9NSN8;
22-339
99.68CA;GOL;
The PDZ domain of SNX27 complexed with the PDZ-binding motif of MERS-E Heteromer
K9N5R3; Q96L92;
22-339
99.69CA;GOL;
The PDZ domain of SNTB1 complexed with the PDZ-binding motif of HTLV1-TAX1 Heteromer
P03409; Q13884;
22-339
99.69CA;EDO;
MAGI1_2 complexed with a phosphorylated 16E6 peptide Heteromer
P03126; Q96QZ7;
22-339
99.69GOL;CIT;CA;
MAGI1_2 complexed with a phosphomimetic RSK1 peptide Heteromer
Q15418; Q96QZ7;
22-339
99.69CIT;GOL;CA;
MAGI-1 complexed with a pRSK1 peptide Heteromer
Q15418; Q96QZ7;
22-339
99.69GOL;CA;
MAGI-1 complexed with a RSK1 peptide Heteromer
Q15418; Q96QZ7;
22-339
99.69GOL;CA;
MAGI1_2 complexed with a phosphomimetic 16E6 peptide Heteromer
P03126; Q96QZ7;
22-339
99.69CIT;GOL;CA;
The PDZ domain of SNTG1 complexed with the acetylated PDZ-binding motif of TRPV3 Heteromer
Q8NET8; Q9NSN8;
22-339
99.69CA;
The PDZ domain of SNTG1 complexed with the phosphomimetic mutant PDZ-binding motif of RSK1 Heteromer
Q15418; Q9NSN8;
22-339
99.69CA;GOL;
The PDZ domain of MAGI1_2 complexed with the PDZ-binding motif of HPV35-E6 Heteromer
P27228; Q96QZ7;
22-339
99.69CA;GOL;CIT;
MAGI1_2 complexed with a 16E6 peptide Heteromer
H7C535; P03126;
22-339
99.69CIT;GOL;CA;
MAGI-1 complexed with a synthetic pRSK1 peptide Heteromer
Q15418; Q96QZ7;
22-339
99.69GOL;CA;
The PDZ domain of SYNJ2BP complexed with the PDZ-binding motif of HTLV1-TAX1 Heteromer
P03409; P57105;
23-339
99.69CA;GOL;
Transactivation domain of p53 in complex with S100P, using annexin A2 as crystallization chaperone Heteromer
P04637; P25815;
29-339
99.67GOL;CA;
The PDZ domain of SYNJ2BP complexed with the PDZ-binding motif of HTLV1-TAX1 Heteromer
P03409; P57105;
29-339
99.68CA;
The PDZ domain of SNTG2 complexed with the phosphorylated PDZ-binding motif of RSK1 Heteromer
Q15418; Q9NY99;
29-339
99.68CA;GOL;
The second PDZ domain of DLG1 complexed with the PDZ-binding motif of HTLV1-TAX1 Heteromer
P03409; Q12959;
30-339
99.68CA;GOL;SO4;
The crystal structure of an AHNAK peptide in complex with the S100A10/AnxA2 heterotetramer Heteromer
P60903; Q09666;
2-14
91.67IPA;
Crystal Structure of p11-Annexin A2(N-terminal) Fusion Protein in Complex with SMARCA3 Peptide Heteromer
P60903; Q14527;
2-14
92.31SO4;
Crystal Structure of the Ternary Complex between S100A10, an Annexin A2 N-terminal Peptide and an A… Heteromer
P60903; Q09666;
2-14
91.67
Structure of human annexin A2 in the presence of calcium ionshomo-2-mer21-339
99.6914×CA;
Annexin A2: Does it induce membrane aggregation by a new multimeric state of the protein.monomer21-339
99.69
Crystal structure of Tyr24 phosphorylated Annexin A2 at 3.4 A resolutionmonomer21-339
99.69CA;
Co-Crystal Structure Analysis of Annexin A2 and 5alpha-EALmonomer22-339
100CA;
SYNJ2BP complex with a synthetic Vangl2 peptide (3mer).monomer22-339
99.69CA;GOL;
The PDZ domain of LRRC7 fused with ANXA2monomer23-339
99.69CA;GOL;
Crystal structure of Tyr24 phosphorylated Annexin A2 at 2.9 A resolutionmonomer23-339
99.69CA;
Structure determination of the transactivation domain of p53 in complex with S100A4 using annexin A…monomer25-339
50.0GOL; 10×CA;
Crystal structure of PKC phosphorylation-mimicking mutant (S26E) Annexin A2monomer29-339
99.68CA;GOL;
The PDZ domain of SNX27 fused with ANXA2monomer29-339
99.68CA;GOL;
Human Annexin A2 with heparin hexasaccharide boundmonomer32-339
100IDS;CA;
Human Annexin A2 with heparin tetrasaccharide boundmonomer32-339
100SGN;CA;
Human Annexin A2 with Calcium boundmonomer32-339
100CA;
Human Annexin A2 with C132-C261 intramolecular disulfide bondmonomer32-339
100
Crystal structure of human Annexin A2 in complex with full phosphorothioate 5-10 2'-methoxyethyl DN…monomer34-339
99.67GOL;CA;MG;
Crystal structure of human Annexin A2 in complex with full phosphorothioate 5-10 2'-methoxyethyl DN…monomer34-339
99.67CA;EDO;

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5lpu.1.Amonomer0.912-339
CA;99.70
5lpu.1.Bmonomer0.892-339
CA;99.70
7qql.3.Amonomer0.882-339
CA;93.79

3 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 25lpu.1.Amonomer0.9020-357
CA;99.70
Isoform 25lpu.1.Bmonomer0.8820-357
CA;99.70
Isoform 27qql.3.Amonomer0.8820-357
CA;93.79